Recent Advances in Granulosa Cell Tumor Ovary: A Review

Indian Journal of Surgical Oncology

Volumn 4, Issue 1, 2013, Pages 37-47

  Kottarathil, Vijaykumar Dehannathparambil ^a,b   Antony, Michelle Aline ^a   Nair, Indu R ^a   Pavithran, Keechilat ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

^b not available   (India)

Author keywords

Granulosa cell tumor; Inhibin B

Indexed keywords

ADENYLATE CYCLASE; ANASTROZOLE; BEVACIZUMAB; BLEOMYCIN; BORTEZOMIB; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ERLOTINIB; ETOPOSIDE; FOXL2 PROTEIN; GEFITINIB; GESTAGEN; GONADORELIN AGONIST; IMATINIB; INHIBIN A; INHIBIN B; LAPATINIB; LETROZOLE; MEDROXYPROGESTERONE ACETATE; MEGESTROL; PACLITAXEL; PAZOPANIB; PHOSPHATIDYLINOSITOL 3 KINASE; PLATINUM DERIVATIVE; SUNITINIB; TAMOXIFEN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE;

ABDOMINAL DISTENSION; ABDOMINAL HYSTERECTOMY; ABDOMINAL MASS; ABDOMINAL PAIN; AMENORRHEA; BREAST AUGMENTATION; BREAST TENDERNESS; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CELL PROLIFERATION; CHROMOSOME 6; CHROMOSOME ABERRATION; CHROMOSOME DELETION; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; ENDOMETRIUM HYPERPLASIA; FEMALE; GRANULOSA CELL TUMOR; HEMOPERITONEUM; HUMAN; HYPOTENSION; IMMUNOHISTOCHEMISTRY; LIVER RESECTION; MENORRHAGIA; MOLECULAR PATHOLOGY; OMENTECTOMY; PEUTZ JEGHERS SYNDROME; PNEUMONIA; POSTOPERATIVE CARE; POTTER SYNDROME; PRIMARY TUMOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALPINGOOOPHORECTOMY; TRISOMY 12; VAGINA BLEEDING;

EID: 84874362603     PISSN: 09757651     EISSN: 09766952     Source Type: Journal    
DOI: 10.1007/s13193-012-0201-z     Document Type: Review

References (80)

1. Ranganath R, Sridevi V, Shirley SS, Shantha V (2008) Clinical and pathologic prognostic factors in adult granulose cell tumors of the ovary. Int J Gynecol Cancer 18: 929-933.
2. Vimla N, Kumar L, Kumar S, Vijayaraghavan M, Bhatla N, Roopa H (2005) Granulosa cell tumors of the ovary: factors affecting prognosis. Indian J Med Pediatr Oncol 26: 12-20.
3. Mehta H, Trivedi P, Parikh B, Shukla K (2005) Clinicopathological prognostic factors of adult granulosa cell tumors of the ovary-a study of 37 cases. Indian J Pathol Microbiol 48: 439-443.
4. Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK (2007) Prognostic factors responsible for survival in sex cord stromal tumors of the ovary: an analysis of 376 women. Gynecol Oncol 104: 396-400.
5. Lee IH, Choi CH, Hong DG, Song JY, Kim YJ, Kim KT (2011) Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol 22: 188-195.
6. Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G et al (2009) Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360: 2719-2729.
7. Jamieson S, Fuller PJ (2012) Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev 33: 109-144.
8. Jakob A, Geiger R, Hirsch FW (2002) Successful treatment of a patient with a granulosa/theca cell tumor of the ovary with STI571 (Gleevec). Proc Am Soc Clin Oncol 21: 24b, Abstract 1904.
9. Tao X, Sood AK, Deavers MT, Schmeler KM, Nick AM, Coleman RL, Milojevic L, Gershenson DM, Brown J (2009) Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors. Gynecol Oncol 114: 431-436.
10. Kesterson JP, Mhawech-Fauceglia P, Lele S (2008) The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report. Gynecol Oncol 111: 527-529.
11. Barrena Medel NI, Herzog TJ, Wright JD, Lewin SN (2010) Neoadjuvant bevacizumab in a granulosa cell tumor of the ovary: a case report. Anticancer Res 30: 4767-4768.
12. Farinola MA, Gown AM, Judson K, Ronnett BM, Barry TS, Movahedi-Lankarani S, Vang R (2007) Estrogen receptor and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors. Int J Gynecol Pathol 26: 375-382.
13. Chu S, Alexiadis M, Fuller PJ (2009) Proteasome inhibition by bortezomib decreases proliferation and increases apoptosis in ovarian granulosa cell tumors. Reprod Sci 16: 397-407.
14. Kruyt FA (2008) TRAIL and cancer therapy. Cancer Lett 263: 14-25.
15. Woods DC, Liu HK, Nishi Y, Yanase T, Johnson AL (2008) Inhibition of proteasome activity sensitizes human granulose tumor cells to TRAIL-induced cell death. Cancer Lett 260: 20-27.
16. Lappöhn RE, Burger HG, Bouma J, Bangah M, Krans M, de Bruijn HW (1989) Inhibin as a marker for granulosa-cell tumors. N Engl J Med 321: 790-793.
17. Petraglia F, Luisi S, Pautier P, Sabourin JC, Rey R, Lhomme C, Bidart JM (1998) Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J Clin Endocrinol Metab 83: 1029-1032.
18. Mom CH, Engelen MJ, Willemse PH, Gietema JA, ten Hoor KA, de Vries EG, van der Zee AG (2007) Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Gynecol Oncol 105: 365-372.
19. Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R, Campbell JJ (1993) Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 329: 1539-1542.
20. Ala-Fossi SL, Aine R, Punnonen R, Mäenpää J (2000) Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors? Eur J Gynaecol Oncol 21: 187-189.
21. Koukourakis GV, Kouloulias VE, Koukourakis MJ, Zacharias GA, Papadimitriou C, Mystakidou K et al (2008) Granulosa cell tumor of the ovary: tumor review. Integr Cancer Ther 7: 204-215.
22. Long WQ, Ranchin V, Pautier P, Belville C, Denizot P, Cailla H, Lhommé C, Picard JY, Bidart JM, Rey R (2000) Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulose cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 85: 540-544.
23. Chang HL, Pahlavan N, Halpern EF, MacLaughlin DT (2009) Serum Mullerian inhibiting substance/anti-Mullerian hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology. Gynecol Oncol 114: 57-60.
24. Anttonen M, Unkila-Kallio L, Leminen A, Butzow R, Heikinheimo M (2005) High GATA-4 expression associates with aggressive behavior, whereas low anti-Mullerian hormone expression associates with growth potential of ovarian granulosa cell tumors. J Clin Endocrinol Metab 90: 6529-6535.
25. Geerts I, Vergote I, Neven P, Billen J (2009) The role of inhibins B and antimullerian hormone for diagnosis and follow-up of granulosa cell tumors. Int J Gynecol Cancer 19: 847-855.
26. Schumer ST, Cannistra SA (2003) Granulosa cell tumor of the ovary. J Clin Oncol 21: 1180-1189.
27. Zhao C, Vinh TN, McManus K, Dabbs D, Barner R, Vang R (2009) Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 33: 354-356.
28. Hauspy J, Beiner ME, Harley I, Rosen B, Murphy J, Chapman W, Le LW, Fyles A, Levin W (2011) Role of adjuvant radiotherapy in granulosa cell tumors of the ovary. Int J Radiat Oncol Biol Phys 79: 770-774.
29. van der Vorst MJ, Bleeker MC, Boven E (2010) Unusual presentation of Granulosa cell tumour of the ovary. J Clin Oncol 28: e554-e556.
30. Ko SF, Wan YL, Ng SH, Lee TY, Lin JW, Chen WJ, Kung FT, Tsai CC (1999) Adult ovarian granulosa cell tumors: spectrum of sonographic and CT findings with pathologic correlation. AJR Am J Roentgenol 72: 1227-1233.
31. Kim SH, Kim SH (2002) Granulosa cell tumor of the ovary: common findings and unusual appearances on CT and MR. J Comput Assist Tomogr 26: 756-761.
32. Chan JK, Zhang M, Kaleb V, Loizzi V, Benjamin J, Vasilev S, Osann K, DiSaia PJ (2005) Prognostic factors responsible for survival in sex cord stromal tumors of the ovary-a multivariate analysis. Gynecol Oncol 96: 204-209.
33. Ayhan A, Salman MC, Velipasaoglu M, Sakinci M, Yuce K (2009) Prognostic factors in adult granulosa cell tumors of the ovary: a retrospective analysis of 80 cases. J Gynecol Oncol 20: 158-163.
34. Sun HD, Lin H, Jao MS, Wang KL, Liou WS, Hung YC, Chiang YC, Lu CH, Lai HC, Yu MH (2012) A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol 24: 244-249.
35. Auranen A, Sundström J, Ijäs J, Grénman S (2007) Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer 17: 1011-1018.
36. Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Pectasides E, Mouratidou D et al (2008) Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res 28: 1421-1428.
37. Sehouli J, Drescher FS, Mustea A, Elling D, Friedmann W, Kühn W, Nehmzow M, Opri F, Klare P, Dietel M, Lichtenegger W (2004) Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients. Anticancer Res 24: 1223-1229.
38. Uygun K, Aydiner A, Saip P, Basaran M, Tas F, Kocak Z, Dincer M, Topuz E (2003) Granulosa cell tumor of the ovary retrospective analysis of 45 Cases. Am J Clin Oncol 26: 517-521.
39. Park JY, Jin KL, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, Nam JH (2012) Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol 125: 80-86.
40. Kyrönlahti A, Rämö M, Tamminen M, Unkila-Kallio L, Butzow R, Leminen A, Nemer M, Rahman N, Huhtaniemi I, Heikinheimo M, Anttonen M (2008) GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors. Endocrinology 149: 5635-5642.
41. Thrall MM, Paley P, Pizer E, Garcia R, Goff BA (2011) Patterns of spread and recurrence of sex cord-stromal tumors of the ovary. Gynecol Oncol 122: 242-245.
42. Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM (2009) Gynecol Oncol 113: 86-90.
43. Fotopolou C, Savvatis K, Braicu EI, Brink-Spalink V, Darb-Esfahani S (2010) Adult granulosa cell tumors of the ovary: tumor dissemination patern at primary and recurrent situation, surgical outcome. Gynecol Oncol 119: 285-290.
44. Abu-Rustum NR, Restivo A, Ivy J, Soslow R, Sabbatini P, Sonoda Y, Barakat RR, Chi DS (2006) Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Gynecol Oncol 103: 31-34.
45. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB, Wharton JT (1987) Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 70: 765-769.
46. Pectasides D, Alevizakos N, Athanassiou AE (1992) Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary. Ann Oncol 3: 316-318.
47. Uygun K, Aydiner A, Saip P, Kocak Z, Basaran M, Dincer M, Topuz E (2003) Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecol Oncol 88: 400-403.
48. Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C (1986) Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 67: 265-268.
49. Zambetti M, Escobedo A, Pilotti S, De Palo G (1990) cisplatinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol 36: 317-320.
50. Pecorelli S, Wagenaar HC, Vergote IB, Curran D, Beex LVA, Witshaw E et al (1999) Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa (-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group Study. Eur J Cancer 35: 1331-1337.
51. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM, Wharton JT (1996) Treatment of poor prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 87: 527-531.
52. Homesley HD, Bundy BN, Hurteau JA, Roth LM (1999) Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 72: 131-137.
53. Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevreau C, Kerbrat P, Morice P, Duvillard P, Lhommé C (2008) Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 18: 446-452.
54. Brown J, Shvartsman HS, Deavers MT et al (2003) The activity of taxanes compared with bleomycin, etoposide and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 97: 489-496.
55. Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet JL (1978) Granulosa cell tumors. A clinical review of 61 cases. Obstet Gynecol 52: 718-723.
56. Savage P, Constenla D, Fisher C, Shepherd JH, Barton DP, Blake P, Gore ME (1998) Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease. Clin Oncol (R Coll Radiol) 10: 242-245.
57. Wolf JK, Mullen J, Eifel PJ et al (1999) Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol 73: 35-41.
58. East N, Alobaid A, Goffin F, Ouallouche K, Gauthier P (2005) Granulosa cell tumour: a recurrence 40 years after initial diagnosis. J Obstet Gynaecol Cancer 27: 363-364.
59. Crew KD, Cohen MH, Smith DH, Tiersten AD, Feirt NM, Hershman DL (2005) Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 96: 235-240.
60. Lordan JT, Jones RL, Karanjia ND, Butler-Manuel S (2007) Debulking hepatectomy for an unusual case of a grade 1 stage 1 granulosa cell tumour of the ovary with late metastases. Oncology 72: 143-144.
61. Lee IW, Levin W, Chapman W, Goldberg RE, Murphy KJ, Milosevic M (1999) Radiotherapy for the treatment of metastatic granulosa cell tumor in the mediastinum: a case report. Gynecol Oncol 73: 455-460.
62. Choan E, Samant R, Fung M, Fung K, Le T, Hopkins L, Senterman M (2006) Palliative radiotherapy for recurrent granulosa cell tumor of the ovary: a report of 3 cases with radiological evidence of response. Gynecol Oncol 102: 406-410.
63. Lee YK, Park NH, Kim JW, Song YS, Kang SB, Lee HP (2008) Characteristics of recurrence in adult-type granulose cell tumor. Int J Gynecol Cancer 18: 642-647.
64. Tresukosol D, Kudelka AP, Edwards CL, Charnsangavej C, Narboni N, Kavanagh JJ (1995) Recurrent ovarian granulosa cell tumor: a case report of a dramatic response to Taxol. Int J Gynecol Oncol 5: 156-159.
65. Malik ST, Slevin ML (1991) Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary: a new therapeutic approach? Br J Cancer 63: 410-411.
66. Isaacs R, Forgeson G, Allan S (1992) Progestagens for granulosa cell tumours of the ovary. Br J Cancer 65: 140.
67. Briasoulis E, Karavasilis V, Pavlidis N (1997) Megestrol activity in recurrent adult type granulosa cell tumour of the ovary. Ann Oncol 8: 811-812.
68. Hardy RD, Bell JG, Nicely CJ, Reid GC (2005) Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature. Gynecol Oncol 96: 865-869.
69. Freeman SA, Modesitt SC (2006) Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases. Gynecol Oncol 103: 755-758.
70. Abdul Munem A, Al-Bahrani B, Mehdi I, Kamona A, Nadas AM (2012) Aromatase inhibitors-a viable option for recurrent granulose cell tumour of ovary: overview and case report. J Pak Med Assoc 62: 505-507.
71. Korach J, Perri T, Beiner M, Davidzon T, Fridman E, Ben-Baruch G (2009) Promising effect of aromatase inhibitors on recurrent granulosa cell tumors. Int J Gynecol Cancer 19: 830-833.
72. AlHilli MM, Long HJ, Podratz KC, Bakkum-Gamez JN (2012) Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature. J Obstet Gynaecol Res 38: 340-344.
73. Martikainen H, Penttinen J, Huhtaniemi I, Kauppila A (1989) Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy. Gynecol Oncol 35: 406-408.
74. Fishman A, Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Kaplan AL, Girtanner RE, Kavanagh JJ (1996) Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 41: 393-396.
75. Kim HJ, Lee S-C, Bae SB, Kwon KW, Kim CK, Lee NS et al (2009) GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors. J Korean Med Sci 24: 535-538.
76. Schwartz PE, MacLusky N, Sakamoto H, Eisenfeld A (1983) Steroid receptor proteins in nonepithelial malignancies of the ovary. Gynecol Oncol 15: 305-315.
77. Kauppila A, Bangah M, Burger H, Martikainen H (1992) GnRHagonist analog therapy in advanced/recurrent granulose cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecol Endocrinol 6: 271-274.
78. Maxwell GL, Soisson AP, Miles P (1994) Failure of gonadotropin releasing hormone therapy in patients with metastatic ovarian sex cord stromal tumors. Oncology 51: 356-359.
79. Ameryckx L, Fatemi HM, De Sutter P, Amy JJ (2005) GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: a case report. Gynecol Oncol 99: 764-766.
80. Adams J (2004) The proteasome: a suitable antineoplastic target. Nat Rev Cancer 4: 349-360.